Priority 3 from the Teenage and Young Adult Cancer PSP
| UNCERTAINTY: What are the best strategies to improve access to clinical trials? (JLA PSP Priority 3) | |
|---|---|
| Overall ranking | 3 |
| JLA question ID | 0060/3 |
| Explanatory note | It is well documented in commentary papers, that young people are less likely to be involved in clinical trials than children or adults. This has an impact on outcome, we now need to describe and test strategies to improve access. |
| Evidence |
None identified |
| Health Research Classification System category | Cancer |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | How can we improve uptake of clinical trials in the TYAC population? ~ How do we improve access of TYA to investigative therapies ~ How can we ensure that new cancer drugs under trial do not exclude people's access by thoughtless use of age boundaries which are not related to the biology or social factors that determine the relevance of the research? |
| Submitted by | 4 x health professionals |
| PSP information | |
|---|---|
| PSP unique ID | 0060 |
| PSP name | Teenage and Young Adult Cancer |
| Total number of uncertainties identified by this PSP. | 185 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 19 January 2018 |